Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bemiparin as Thromboprophylaxis After Surgery in Morbidly Obese Patients
NCT05569681Completed
- Sponsor
- Hawler Medical University
- Start
- Jan 2023
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of bemiparin in venous thromboembolism (VTE) (2 arms), sponsored by Hawler Medical University. Primary endpoint: Number of participants with Venous Thromboembolism events at 30 days. Started Jan 2023; status: completed.
02
Drugs
bemiparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT05569681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05569681.